You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 90 No. 6, December 1964 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Percutaneous Salicylic Acid Intoxication in Psoriasis

JOHN F. von WEISS, MD; WALTER F. LEVER, MD

Arch Dermatol. 1964;90(6):614-619.


Abstract

Three adults with extensive psoriasis were treated with an ointment containing 3% or 6% salicylic acid incorporated in either Eucerin or hydrophilic ointment USP XV. This was applied six times a day. Between the second and the fourth day, symptoms of salicylism developed in all three patients. The outstanding symptoms were nausea, dyspnea, decreased ability to hear, confusion, and hallucinations. The levels of salicylic acid in the serum ranged from 46 to 64 mg/100 ml. Within one day after discontinuing the applications of the salicylic acid ointment, the symptoms had largely disappeared. The levels of salicylic acid in the serum decreased to zero within a few days.



Author Affiliations

BOSTON

From the Department of Dermatology, Tufts University School of Medicine and the Dermatology Service, Boston Dispensary (Tufts-New England Medical Center).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Safety Assessment of Salicylic Acid, Butyloctyl Salicylate, Calcium Salicylate, C12-15 Alkyl Salicylate, Capryloyl Salicylic Acid, Hexyldodecyl Salicylate, Isocetyl Salicylate, Isodecyl Salicylate, Magnesium Salicylate, MEA-Salicylate, Ethylhexyl Salicylate, Potassium Salicylate, Methyl Salicylate, Myristyl Salicylate, Sodium Salicylate, TEA-Salicylate, and Tridecyl Salicylate
International Journal of Toxicology 2003;22:1-108.
ABSTRACT  

Refractory Hypoglycemia Secondary to Topical Salicylate Intoxication
Raschke et al.
Arch Intern Med 1991;151:591-593.
ABSTRACT  

Absorption of Salicylic Acid
Soyka and Soyka
JAMA 1980;244:660-661.
ABSTRACT  

Vasoconstrictor and Systemic Activities of Topical Steroids
Child et al.
Arch Dermatol 1968;97:407-410.
ABSTRACT  

PERCUTANEOUS SALICYLIC ACID INTOXICATION
JAMA 1964;190:1064-1064.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1964 American Medical Association. All Rights Reserved.